Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Abnormal Uterine BleedingInfertility
Interventions
DEVICE

Interlace Medical 1st Generation Hysteroscopic Morcellator

The Interlace Medical hysteroscopic morcellator system has been cleared by the FDA(K073690)and consists of a motor drive unit connected to a 3mm morcellator. The morcellator is approximately 12 cm long and is equipped with an open channel that houses a reciprocating blade. When the motor is activated, the reciprocating blade will cut the tissue within the channel. The tissue travels down the 3mm morcellator shaft cannula via suction coupled to the proximal end of the morcellator and is captured in a tissue trap in a suction canister for pathological diagnosis following the procedure.

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Hologic, Inc.

INDUSTRY

NCT01026805 - Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator | Biotech Hunter | Biotech Hunter